NCT03188341

Brief Summary

The vascular surgery is a highest risk procedure when considering postoperative complications associated with the cardiovascular system. The leading clinical presentation is acute hemodynamic decompensation. However, one of the possible pathomechanisms might be repolarization disturbances. Many of perioperative risk factors of cardiac complications are modifiable. The identification may help in the global perioperative risk reduction. Aim: The aim of the study was an identification of the factors which may release clinically overt repolarization disturbances. Methods: The study group consisted of 100 patients, diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure. The authors investigated whether age, gender, comorbidities or some perioperative factors (including hemodynamic, metabolic or genetic) were related to the occurrence of clinically concealed repolarization disturbances or clinically disclosed cardiac complications in postoperative time up to 30 day and one year after vascular surgery procedure.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2010

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

June 8, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 15, 2017

Completed
Last Updated

June 15, 2017

Status Verified

June 1, 2017

Enrollment Period

6 years

First QC Date

June 8, 2017

Last Update Submit

June 13, 2017

Conditions

Keywords

vascular surgeryrepolarization disturbancescardiac complicationshigh risk patienthigh risk procedure

Outcome Measures

Primary Outcomes (1)

  • cardiac complications

    cardiac complications according to European Society of Cardiology

    up to 30 days after vascular procedure

Secondary Outcomes (2)

  • cardiac complications

    during surgical procedure

  • cardiac complications

    one year

Study Arms (1)

vascular surgery patients

* clinically concealed repolarization disturbances during vascular surgery procedure * clinically disclosed cardiac complications during and after vascular surgery procedure

Other: vascular surgery procedure

Interventions

* an elective "open" vascular surgery procedure * ECG Holter recording during the procedure and 24 hours after operation (continuous electrocardiographic tracing (digital Holter ECG monitor)

vascular surgery patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure. The study was conducted by the team from Department of Anaesthesiology, Intensive Care and Acute Poisoning of the tertiary teaching hospital at the Pomeranian Medical University in Szczecin, Poland.

You may qualify if:

  • adult patients diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure

You may not qualify if:

  • heart stimulation,
  • atrioventricular and intraventricular conduction defects,
  • atrial fibrillation recorded before of the study,
  • antiarrhythmic drug treatment (except beta-blockers),
  • unoptimal patient general status (uncontrolled diabetes, active infection)
  • reoperation
  • emergency operations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

Metabolic monitoring consisted of electrolytes and arterial blood gas analysis prior to anesthesia induction and at the end of the procedure. Blood was drawn into anticoagulant for genetic studies. Genomic DNA was isolated from peripheral blood leukocytes to investigate rs203462 AKAP10 polymorphism in the study population.

MeSH Terms

Conditions

Aortic Aneurysm, AbdominalPeripheral Arterial Disease

Interventions

Vascular Surgical Procedures

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic DiseasesAtherosclerosisArteriosclerosisArterial Occlusive DiseasesPeripheral Vascular Diseases

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Jowita Biernawska, MD, PhD

    Department of Anaesthesiology and Intensive Care of the Pomeranian Medical University in Szczecin, Poland.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

June 8, 2017

First Posted

June 15, 2017

Study Start

December 1, 2010

Primary Completion

December 1, 2016

Study Completion

June 1, 2017

Last Updated

June 15, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share